Analysts expect revenue increase Johnson & Johnson

For this year Johnson & Johnson 's revenue will be around 81,11 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 76,45 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

financial analysis

The analysts expect for 2018 a net profit of 22,09 billion USD. For this year most of the analysts expect a profit per share of 8,1 USD. The price/earnings-ratio therefore equals 15,73.

For this year the analysts expect a dividend of 3,58 USD per share. Thus the dividend yield equals 2,81 percent. The average dividend yield of the health care companies equals a limited 1 percent.

Latest estimates around 164 USD

The most recent recommendations for the health care company are from Jefferies & Co., Leerink Swann & Company and RBC Capital Markets.

Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 344,76 billion USD.

At 15.41 the stock trades 0,19 percent lower at 127,38 USD.

Historical stock prices Johnson & Johnson past 10 years

financial analysis johnson&johnson News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.